biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Does xB3 Work?

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Aug 21, 2023 7:40pm

52 Views

Post# 35598943

RE:RE:RE:RE:RE:RE:Does xB3 Work?

I'm not interested in outsmarting you, TT.

You only have a couple of repetitive thinbgs to say, TT, and I gave you those! It's beneath me to take that on.

Let me inflame you just a little bit more.

xB3 works. That's why LT and The Gang want it. And why Rathjen & Saltarelli were going to join them.

One more.

Maybe you should take a run at Saltarelli. He says he believes that xB3 could be better than Denali's three billion dollar Transport Vehicle.

You're not calling Saltarelli a liar, are you?

jd

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale